Anti-IDH1/2 Mutant (R132/172) Antibody, clone MsMab-1
|
|
- $416
- Product name: Anti-IDH1/2 Mutant (R132/172) Antibody, clone MsMab-1
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:Anti-IDH1/2 Mutant (R132/172) Antibody, clone MsMab-1
1 prices
Selected condition：
Brand
- Sigma-Aldrich
Package
- 100μg
- ManufacturerSigma-Aldrich
- Product numberMABC1103
- Product descriptionAnti-IDH1/2 Mutant (R132/172) Antibody, clone MsMab-1 clone MsMAb-1, from mouse
- Packaging100μg
- Price$416
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Sigma-Aldrich | MABC1103 | Anti-IDH1/2 Mutant (R132/172) Antibody, clone MsMab-1 clone MsMAb-1, from mouse | 100μg | $416 | 2024-03-01 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Immunohistochemistry Analysis: A 1:50 dilution from a representative lot detected IDH1/2 Mutant (R132/172) in human colon, human colorectal cancer, and human ovarian cancer tissue.Western Blotting Analysis: The mutant selectivity of a representative lot was tested against purified IDH1/2 MBP fusion constructs as well as lysates from CHO cells expressing exogenously expressed IDH1/2 proteins (Kato Kaneko, M., et al. (2013). Tohoku J Exp Med. 230(2):103-109; Liu, X., et al. (2013). Cancer Med.;2(6):803-814).
Western Blotting Analysis: A representative lot detected exogenously expressed IDH2- R172S, but not wild-type IDH2 or IDH2-H175Y PA fusion proteins in lysates from transfected U2OS osteosarcoma cells (Kato Kaneko, M., et al. (2014). Cancer Sci.;105(6):744-748).
Immunohistochemistry Analysis: A representative lot detected IDH2 R172S mutant, but not wild-type IDH1/2, in paraffin-embedded human GCTB (giant cell tumor of bone) tissue sections (Kato Kaneko, M., et al. (2014). Cancer Sci.;105(6):744-748).
Immunohistochemistry Analysis: A representative lot detected IDH2 R172S mutant, but not wild-type IDH1/2, in paraffin-embedded human osteosarcoma tissue sections (Liu, X., et al. (2013). Cancer Med.;2(6):803-814).